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Abstract 
CYP2A6 is a human enzyme responsible for the metabolic elimination of nicotine, and it is also involved in 
the activation of procarcinogenic nitrosamines, especially those present in tobacco smoke. Several 
investigations have reported that reducing this enzyme activity may contribute to anti-smoking therapy as 
well as reducing the risk of promutagens in the body. For these reasons, several authors investigate 
selective inhibitors molecules toward this enzyme. The aim of this study was to evaluate the interactions 
between a set of organosulfur compounds and the CYP2A6 enzyme by a quantitative structure-activity 
relationship (QSAR) analysis. The present work provides a better understanding of the mechanisms 
involved, with the final goal of providing information for the future design of CYP2A6 inhibitors based on 
dietary compounds. The reported activity data were modeled by means of multiple regression analysis 
(MLR) and partial least-squares (PLS) techniques. The results indicate that hydrophobic and steric factors 
govern the union, while electronic factors are strongly involved in the case of monosulfides.  
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Introduction 
Cytochrome P450s (CYPs) comprise a superfamily of heme-containing enzymes responsible for the 
metabolism of numerous compounds, therefore they are important objects of study mainly in the areas of 
pharmacology and toxicology [23]. CYPs are known for the diversity of reactions they catalyze, as well as, 
the range of different molecules with whom they interact. Cytochrome P450s are responsible for the 
majority of Phase I metabolism of exogenous molecules such as drugs, xenobiotics, environmental 
pollutants, dietary compounds, and endogenous molecules such as steroids, fatty acids, and prostaglandins 
[3,5,10]. The effects of these transformations can be manifested in drug bioavailability and toxicity, adverse 
drugs interactions, activation of procarcinogenic compounds, and biotransformation of molecules for 
subsequent elimination [8,9]. 
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Among the CYP enzymes, CYP2A6 is the only member of the 2A subfamily that is expressed in humans 
and it catalyzes the coumarin 7-hydroxylation reaction (marker substrate)[5,6,23]. The current interest in 
CYP2A6, its polymorphisms and alleles, is mostly due to its effects on tobacco addiction, and the 
subsequent impact on lung cancer. Accordingly, two important features are noteworthy: CYP2A6 is the 
major catalyst of metabolic elimination of nicotine, and it is also involved in the activation of 
procarcinogenic nitrosamines, especially those present in tobacco smoke [14].  
On the other side, nicotine is the essential component that causes tobacco dependence. The 
pharmacological, as well as, physiological effects of smoking are due to this alkaloid. Pulmonary absorption 
of nicotine is extremely rapid, and once it is absorbed, it is rapidly and extensively metabolized and 
eliminated through urine. In general, 70-80 % of its biotransformation consists mainly in the oxidation of  
(-)-nicotine to form (-)-cotinine mediated by CYP2A6. Nicotine is also metabolized to nornicotine, via N-
demethylation. In humans, 2-3 % of nicotine is excreted as nornicotine in 24 h urine [5,20,21]. Several 
nicotine preparations have been developed as a medication to assist in smoking cessation; also other 
therapies and treatments have been proposed to reduce tobacco consumption, among them, we can name 
the use of nicotine patches, dopamine uptake inhibitor (bupropion), consumption of tricyclic 
antidepressants and buspirone anxiolytic. However, the previous therapies are of limited use because of 
the secondary effects that come with them and due to a low proven success (below 40%), for this reasons 
alternative treatments are encouraged [22]. With this goal, several investigations have shown that the 
inhibition of CYP2A6 by different chemical compounds may represent a potential supplement to anti-
smoking therapy [12]. The efficiency of CYP2A6-mediated biotransformation of nicotine is associated with 
nicotine blood levels for keeping the addiction liability. Potent and specific inhibitors of CYP2A6 might 
increase nicotine half-life elimination time. Consequently, the inhibition of CYP2A6 results in a diminished 
desire to smoke and a reduced consumption of toxic or carcinogenic components of cigarette smoke [17]. 
Moreover, the administration of chemicals that strongly and specifically inhibit the CYP2A6 activity might 
also result in a reduction of mutagens in the body, since the N-nitrosamines activation does not occur when 
this enzyme is altered [5].  
Numerous compounds have been proposed and tested as CYP2A6 inhibitors, among them methoxsalen, 
(R)-(+)-menthofuran, and tranylcypromine can be mentioned. Even though they have shown strong 
inhibitory effects, methoxsalen and tranylcypromine also inhibited other forms of CYP [5]. On the other 
hand, in silico studies, such as QSAR models, serve to predict and explain molecular properties and/or 
biological activities from the structure of chemical compounds reducing the number of tests, thereby 
resulting in a quick and simple alternative for designing new drugs with a desirable effect. In this sense, 
some authors have carried out in silico studies to predict selective CYP2A6 inhibitors based on a series of 
nicotine derivatives [17], naphthalene and non-naphthalene derivatives [11,15], or based on virtual 
screening of a large number of compounds [13]. To date, all the studied in silico inhibitors are from 
synthetic origin. However, it has been proved that some sulfide and disulfide compounds present in Allium 
vegetables, inhibit CYP activity. In this sense, the anticarcinogenic and antitumorigenic effects of garlic in 
rodents have been attributed to modulation of CYP activity for some OSCs such as diallyl sulfide (DAS), 
diallyl disulfide (DADS) and allyl methyl sulfide (AMS) [7,16]. Fujita and Kamataki, (2001) [5] studied the 
inhibition of CYP2A6 by determining the ability of 22 organosulfur compounds to inhibit coumarin 7-
hydroxylase activity. Based on these experimental values, we carried out a quantitative structure-activity 
relationship (QSAR) analysis to evaluate these inhibitors-enzyme interactions in order to obtain a wider 
vision into the mechanisms involved. In turn, a potential selective inhibitor of CYP2A6 based on naturally 
occurring compounds can be proposed. The reported activity data were modeled by means of multiple 
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regression analysis (MLR) and partial least-squares (PLS) techniques. For the quantitative description of the 
analyzed structures, different quantum chemical indices (AM1) and physicochemical parameters were 
calculated. Non-empirical descriptors, such as topological and geometrical, were also used as descriptive 
variables. Finally, the obtained results provided an explanation about which are the main features and 
parameters of OSCs (lipophilicity, steric and electronic features) that contribute to an optimal inhibitory 
activity on CYP2A6. 
Materials and methods 
Biological and chemical data 
The chemical structures along with observed activity data of the compounds used in this study are 
shown in Table 1. The inhibitory activity data on CYP2A6 were obtained from Fujita and Kamataki, (2001) 
[5], and it was expressed as percentage of Residual Activity (RA%) when using 10 µM of each inhibitor and 
2.5 µM of coumarin. In order to evaluate whether the biological data comes from a normal distribution, the 
standardized skewness and kurtosis values were calculated for RA% (n=22).  
Structural descriptors 
A set of molecular descriptors were calculated to characterize the compounds under study. As for 
indicators of molecular size, the following were considered: molar volume (Vm), molecular weight (MW), 
and molar refractivity (MR). To explain lipophilicity effects, several calculated partition coefficients were 
obtained by using ALOGPS 2.1 software (log Pexp, ALOGPs, IA Log P, COSMOFrag, miLog P, KOWWIN and 
XLOGP). Another group of structural descriptors included quantum chemical indices obtained by 
HyperChem package (release 7.5 for Windows). Three-dimensional molecular structures were built using 
the MM+ molecular mechanics potential-energy function. In a follow-up procedure, complete optimization 
of the geometrical parameters was carried out by using the AM1 method, implemented in the standard 
version of MOPAC 6.0. The following indices obtained from molecular orbital calculations were considered: 
total energy (Etotal), heat of formation (¢Hf), energy of highest occupied molecular orbital (HOMO), energy 
of lowest unoccupied molecular orbital (LUMO), dipole moment (µ), absolute total charge (Qtotal), the most 
positive and the most negative absolute charges (qp,max, qn,max), and the positive and negative relative 
charge (RNCG, RPCG). The last group of descriptors considered in this study included various geometrical 
and topological indices: the Wiener index, the valence and connectivity molecular indices, the kappa shape 
indices, and several geometrical indices calculated from the optimized distance matrix AM1 by using 
Dragon software (v 3.0). A stepwise multiple regression procedure, based on the algorithms forward-
selection and backward-elimination, was used for the inclusion or rejection of descriptors in the screened 
models.  
Statistical methods 
Partial least squares projections in latent variables (PLS) together with multiple regression analysis 
(MLR) were the selected methods to search for relationships between the biological activity data and the 
structural descriptors. The determination of the significant number of PLS components was made by 
crossvalidation [1,19]. PLS analysis was carried out using the SIMCA-P 7.01 software obtained from Umetri 
AB, Umea, Sweden, and MLR analysis was performed using the 7.0 version of Statgraphics Plus software. 
Prior conducting the PLS-1 analysis for each one of the classes, all the variables were auto-scaled to zero 
mean and unit variance. This transformation assures data standardization and allows to give each 
descriptor equal importance in the PLS analysis. To avoid overestimations or misunderstanding 
interpretation of the resulting models, pairs of variables with r ≥ 0.75 were classified as intercorrelating 
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ones, and only one of these was included in the screened model.  The predictive ability of the model was 
evaluated by the crossvalidation coefficient (Q2), which is based on the prediction error sum of squares 
(PRESS). The PRESS statistic is computed as the squared differences between observed and predicted 
values when the observations are kept out of the derived model. This procedure is repeated several times 
until every observation has been kept out once, and only once. 
Results  
Multiple regression analysis 
MLR was performed on the 22 OSCs described in Table 1, whereas Table 2 shows the molecular 
descriptors included in the selected models. 
Table 1. CYP2A6 Inhibitory Activity Data of Organosulfur Compounds 
N° Name Chemical structure 
Residual 
Activity % 










3 Diethyl sulfide S CH3CH3  
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N° Name Chemical structure 
Residual 
Activity % 
18 Phenyl ciclopropyl sulfide 
S  
42.1 



























Table 2. Molecular Descriptors
a
 for the compounds described in Table 1 
N° RA% CLOGP Ehomo Elumo µ LDip RPCG RNCG E1u E3u SPAM ASP Qmean 
1 98.400 0.845 -8.882 0.457 1.961 0.251 0.200 0.484 0.707 0.444 0.517 0.237 0.093 
2 94.100 0.845 -9.399 -1.978 2.569 0.249 0.193 0.473 0.724 0.449 0.545 0.235 0.095 
3 89.400 1.817 -8.856 0.362 1.941 0.154 0.118 0.282 0.654 0.533 0.488 0.665 0.076 
4 79.600 1.817 -9.352 -1.976 2.646 0.160 0.132 0.289 0.676 0.484 0.504 0.521 0.078 
5 83.400 2.604 -8.857 0.353 1.910 0.146 0.090 0.216 0.632 0.571 0.480 0.765 0.074 
6 39.500 2.604 -9.351 -1.996 2.660 0.151 0.103 0.230 0.677 0.358 0.489 0.547 0.075 
7 82.000 3.291 -8.861 0.342 1.886 0.134 0.071 0.170 0.612 0.593 0.475 0.875 0.073 
8 43.900 3.291 -9.351 -1.999 2.676 0.139 0.083 0.183 0.642 0.367 0.477 0.659 0.074 
9 88.800 3.911 -8.865 0.337 1.881 0.129 0.059 0.141 0.605 0.606 0.472 0.900 0.072 
10 66.300 3.911 -9.354 -2.002 2.677 0.133 0.069 0.153 0.643 0.374 0.473 0.681 0.073 
11 91.300 2.352 -8.901 -0.068 2.004 0.153 0.133 0.169 0.594 0.348 0.525 0.763 0.100 
12 46.200 2.352 -9.313 -2.010 2.650 0.157 0.127 0.171 0.626 0.294 0.515 0.346 0.102 
13 97.600 1.672 -8.894 0.146 1.987 0.187 0.178 0.314 0.590 0.310 0.527 0.604 0.098 
14 94.200 2.459 -8.880 0.108 1.958 0.150 0.139 0.209 0.594 0.353 0.518 0.778 0.086 
15 32.800 3.437 -8.566 -0.076 1.649 0.140 0.113 0.161 0.574 0.227 0.514 0.642 0.105 
16 46.100 4.412 -8.371 -0.142 1.265 0.127 0.130 0.127 0.613 0.000 0.474 0.615 0.110 
17 65.700 4.412 -8.960 -2.164 2.495 0.139 0.096 0.188 0.624 0.331 0.477 0.484 0.105 
18 42.100 3.527 -8.557 0.086 1.627 0.158 0.105 0.217 0.618 0.172 0.467 0.524 0.112 
19 69.100 1.182 -9.143 -2.170 2.191 0.126 0.123 0.152 0.627 0.376 0.519 0.749 0.101 
20 97.000 1.406 -9.320 -2.365 5.911 0.140 0.108 0.158 0.602 0.248 0.498 0.471 0.105 
21 3.220 1.406 -9.007 -0.667 0.321 0.135 0.160 0.133 0.620 0.000 0.487 0.630 0.113 
22 2.260 1.406 -9.573 -2.627 0.150 0.121 0.111 0.160 0.602 0.248 0.500 0.534 0.108 
   
a
 For an explanation of the symbols, refer to the text 
First, in order to evaluate the data set distribution the standardized skewness and kurtosis values were 
calculated for RA% (n=22). Skewness is a measure of symmetry, or more precisely, the lack of symmetry; 
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and Kurtosis indicates whether the data distribution is heavy-tailed or light-tailed relative to a normal 
distribution. In other words, data sets with high kurtosis tend to have heavy tails, or outliers. The obtained 
results considering RA% were -1.5517 and -0.2634 for the standardized skewness and kurtosis values, 
respectively. Values outside -2 to +2 range indicate significant departures from normality. In this case, the 
obtained values are within the expected range for data presenting normal distribution.   
On the other hand, because of the large number of structural descriptors considered in this study, the 
VIP (variable importance for the projection) parameter [18] was used to unravel which descriptors were 
relevant to explain the enzyme activity. VIP is based on the PLS projection method, which constitutes a 
robust method for variables selection. 
Considering the arguments presented by Yano et al. (2006) [22] along with other background QSAR 
studies about CYP2A6 enzyme, which showed that the nature of the enzyme active site is strongly 
hydrophobic, it was decided first, to study the relationship between activity and lipophilicity. After using 
several calculated log P parameters, the obtained equations showed no significant correlations in this 
direction. On the other hand, since lipophilicity can be described by the contribution of the molecular size 
and molecular polarity, models that incorporated both molecular properties were investigated. The best 
regression equation that includes the parameter CLOGP, was:   
 
RA% = -193.05 (30.01) + 11.60 (3,13) CLOGP + 17.76 (2.50) µ  (1) 
            (0.000)                 (0.002)                       (0.000)  
 
                   + 126.33 (16.40) E3u + 823.4 (113.5) RPCG + 81.78 (18,63) ASP 
                      (0.000)                       (0.000)                        (0.000)                                                   
 
R2 = 0.90; R2(cv) = 0.673; s = 10.83; n = 22; F = 28.77; WCLOGP = 0.441; Wµ = 0.646; WE3u = 0.693; WRPCG = 
1.041; WASP = 0.489 
 
In equation (1) and the following equations, n is the number of compounds, s is the standard deviation, 
R2 is the squared correlation coefficient, R2(cv) is the squared crossvalidation coefficient, and F is the Fisher 
F statistic. Values in parentheses correspond to the standard deviations and p-values of coefficients, and 
the term W, represents the standardized regression coefficient when variables are scaled to the same 
numerical range (0-1).  
The statistical quality of the model is suitable. Although the relationship between numbers of 
observations versus the number of variables is high, the good quality in fit and predictive ability, as 
expressed by R2 and R2(cv) coefficients, suggests that the obtained model is valid.  
Other models were also investigated, in which the relationship between observations / variables were 
lower in relation to the previously derived equation. 
RA% = 301.77 (82.54) + 39.177 (9.379) Ehomo + 130.41 (18.08) E3u  (2) 
           (0.002)                (0.001)                             (0.000)  
 
              + 15.155 (2.744) µ + 333.23 (76.60) RPCG  
                 (0.000)                   (0.000)                   
 R2 = 0.853; R2(cv) = 0.783; s = 12.71; n = 22; F = 24.71; WEhomo = 0.415; WE3u = 0.715; Wµ = 0.551; WRPCG = 
0.421 
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This equation is highly significant, and the molecular descriptors here used, did not show significant 
intercorrelations. Figure 1 shows the relationships between the experimental and calculated Residual 
Activity (RA%) for equations (1) and (2), respectively. An interesting point to highlight in this equation is an 
improvement in the crossvalidation coefficient value, which suggests a better predictive ability. 
 
Figure 1. Relationship between observed and 
calculated values for (a) equations (1) and (b) 
equation (2) 
An alternative way to evaluate the reliability and robustness of a QSAR model consists in applying 
different statistical approaches, but using the same descriptors that have been included in the original 
model. Accordingly, a linear discriminant analysis (LDA) was carried out based on the molecular descriptors 
used in equation (2) to maintain an adequate balance between the numbers of observations vs. the 
number of independent variables. Taking into account the information from the inhibitory activity data, the 
compounds were separated into three groups, namely highly active (RA% 1-10), active and weakly active 
(RA% 11-70) and weakly active or inactive (RA% 71-100). The discriminant ability was assessed by the 
correct classifications percentage, and the discriminant function quality was evaluated using the Wilks 
parameter, λ, which was obtained by a multivariate analysis of variance that tests the equality of group 
means for the variable in the discriminant model. The first standardized discriminating function was: 
DF1 = 1.842 Ehomo + 1.699 µ + 1.884 E3u + 1.063 RPCG (3) 
F = 132.14; Wilks’ lambda (λ) = 0.0627; P(value) = 0.0000; n = 22 
This equation is highly significant as P < 0.00001, and amongst the 22 observations used to fit the 
model, 22 (or 100.0 %) were correctly classified. In order to check an overestimation of the obtained 
model, the rate of correct classification was evaluated by using crossvalidation and a 95.5% was obtained 
(21 to 22). From the relative magnitude of the obtained coefficients in equation (3), it can be appreciated 
the contribution of a single variable to discriminate amongst the groups. Figure 2 plots each observation in 
the space of the two linear discriminant functions (DF1, DF2). 
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Figure 2. 2-D plot of discriminant functions DF1 and DF2. 
The fact that similar conclusions are obtained by using both kinds of statistical methods; that is, MLR 
and LDA, provides more evidence about the model robustness here reported.  
The data set, includes both monosulfides as disulfides. In the case of monosulfides, these can act as 
strong nucleophiles (Nuθ) or reducing agents depending on the nature of the electrophile(E⊕), the 
substituent group (R-S), and the medium in which the reaction occurs. Such property is related to the Ehomo 
energy of monosulfides, thus, a greater Ehomo implies a higher ionization potential and a superior ability to 
donate electrons. Moreover, disulfides act as electrophilic oxidants, i.e. tend to accept electrons, which is 
reflected by their low LUMO energy orbital. Considering the above, the set of compounds under study was 
divided among mono- and disulfides, which were analyzed independently. The relationship between 
monosulfides and their corresponding Ehomo energy showed a parabolic correlation as presented in 
Equation (4). 
RA% = 30195 (5506) + 7083 (1272) Ehomo + 415.83 (73.42) Ehomo
2  (4) 
            (0.001)            (0.001)                       (0.000)                          
                                                     
 R2 = 0.968; R2(cv) = 0.909; s = 4.82; n = 11; F = 122.28; WEhomo = 0.535; WEhomo
2 = 0.544 
The quadratic term Ehomo is statistically significant (p = 0.000), although this term depends very strongly 
on compound 16. Thus, only the analysis of a data serie including a larger amount of monosulfides would 
help to validate the parabolic relationship obtained. Another aspect to highlight, is that compound 21 (4,4'- 
dipyridyl sulfide) was excluded from the analysis because it presented an outlier behavior, given its polarity 
and structural nature, that differs from the other monosulfides (this may be due to the fact that compound 
21 is the only pyridyl monosulfide compound).  
In the case of the 10 disulfides under study, the best-obtained regression equation was:  
RA% = -171.4 (35.97) + 16.871 (2.114) µ + 294 (46.64) E3u + 907.1 (243.2) Qmean (5) 
            (0.003)              (0.000)                 (0.001)                 (0.010) 
 






























Class 1 : Range 70-100 RA %
Class 2 : Range 10-70    RA %
Class 3 : Range  1-10     RA %
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In Figure 3, it is possible to observe an agreement between the experimental and calculated values of 
RA%, as well as the normal distribution of residual values. The values of the correlation coefficient (r) 
between pairs of variables used in this equation showed an acceptable intercorrelation: µ/E3u -0.099, 
µ/Qmean -0.028, and E3u/Qmean -0.586. 
 
Figure 3. Relationship between observed and calculated values for equation (4). 
Partial least square-1 regression analysis 
A preliminary analysis of different PLS models performed on the whole series of compounds showed 
that the most important variables were those that had been useful in the regression analysis. Finally, the 
analysis of molecular descriptors was performed using PLS-pseudoregression coefficients, and the 
statistical significance of all QSAR-PLS derivatives models was evaluated by means of the following 
statistical parameters: variance of the matrices X and Y (R2X and R2Y), the correlation coefficient (r), 
standard deviation (RMSS) and the statistical F. 
The PLS model was built using 21 of the total set of OSCs; compound 15 (allyl phenyl sulfide) was not 
included in the model because of its outlier behavior, as observed in MLR-QSAR models. The PLS-1 analysis 
resulted in two statistically significant components (CPLS), which statistical parameters are detailed in Table 
3. 
Table 3: Statistical parameters and PLS model 
Comp. R2X(CUM) R2Y(CUM) Q
2
(CUM) RMSS F statistical 
CPLS-1 0.400 0.587 0.418 
9.1347 122.380 
CPLS-2 0.566 0.914 0.817 
 
(r=0.965)  (q=0.904) 
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Figure 4. Relationship between observed and calculated values by the PLS-1 model derived. 
Figure 4, shows the relationship between RA% experimental values and the corresponding calculated 
values derived from the PLS-1 models. As can be observed in Figure 5, the normal probability plot of the 
residuals is approximately linear, which indicates that the error terms are normally distributed. Moreover, 
the corresponding pseudoregression coefficients are shown in Figure 6. From these values, it can be 
observed how much a single variable contributes to RA% modelling. 
 
Figure 5. N-probability plot of residuals from the PLS-1 model. 
 
Figure 6. Bar graph of the standardized coefficients of the PLS-1 model. 
D.A. Ramirez et al.                                                ADMET & DMPK 7(3) (2019) 196-209 
206  
Validation of PLS-1 model 
The actual predictive ability of a QSAR model can be judged using compounds not included originally in 
the calibration series, or alternatively, by using a permutation method [4]. Thus, to show that the 
developed PLS-1 model was not a result of chance, both validation methodologies were used. RA values 
[%], predicted for 4 unused compounds are shown in Table 4. As can be seen, predictions are within the 
range of experimental error, so they are quite acceptable. It should be mentioned that the classification 
model using LDA, as previously shown in equation (3), correctly predicts the activity of the four inhibitors 
shown in Table 4. 
Table 4. Predictions from the derived QSAR model 







Nicotine 98.1 91.614 0.03391 
Tranylcypromine 12.9 29.952 0.31252 
Cotinine 96.2 99.324 0.00343 
SM-12502 85.9 84.476 0.01204 
a
 Activities expressed as RA% (Source: Fujita and Kamataki, 2001) 
b
 Predicted activity values (RA%) using the developed PLS-1 model 
c
 Probability of belonging to the descriptor space used in the model. In this case, tranylcypromine and SM-12502 they 
belong, while nicotine and cotinine are borderline. 
As previously mentioned, the validity of the PLS-1 model was additionally tested by a permutation test. 
Models were recalculated for randomly reordered response data (RA%). These permuted RA% values were 
related to intact predictor data by refitting the model and including crossvalidation. When R2 and Q2 were 
plotted as a function of the correlation coefficient between the original values and the predicted values, 
the interception point with the Y axis expressed how much these values rely on chance. In Figure 7, the 
corresponding plot of RA% response permutation test is presented. The vertical axis gives the R2 and Q2 
values of each test. The horizontal axis represents the correlation coefficient between the observed and 
the permuted RA% values (200 permutations of the RA% dependent variable under study). 
 
Figure 7. Permutation graph of the PLS-1 derived model. 
The intersection of the two regression lines (for R2 and Q 2) in the figure indicates the degree of 
overshooting and predictability. In general, the valid model limits include values of R2 <0.30 and Q 2 <0.30. 
This condition is fulfilled, indicating that the PLS-1 model obtained is suitable both, for its adjustability as 
for its predictive ability. 
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Discussion 
The QSAR models here proposed showed the main factors prevailing the OSC-CYP2A6 binding. Several 
statistical analyses were carried out for this purpose. Four equations resulted from the Multiple Regression 
Analysis. The presence of CLOGP in equation (1) suggests that the molecular lipophilicity plays an essential 
role in the inhibition of CYP2A6. This fact was experimentally demonstrated by Yano et al. (2006) [22] and 
corresponds with the hydrophobic nature of the active site. On the other hand, equation (1) shows a high 
influence of the molecular shape in the inhibition process, as expressed by the ASP and E3u descriptors. 
The presence of the ASP (asphericity) descriptor, which is a measure of the spherical shape deviation of the 
molecule, allows us to infer that at higher molecular elongation, a more significant inhibitory activity can be 
observed. Regarding the E3u geometric descriptor, which belongs to the directional WHIM descriptors 
encoding the planar characteristics of the molecules, it will acquire values tending to zero for molecules 
ideally planar, and values tending to one for molecules that deviate from this property. Thus, considering 
equation (1) for the compounds under study, it was observed that compounds having lower E3u descriptor 
value, generally exhibit a higher inhibitory capacity.  
Furthermore, from the analysis of equation (1), it was observed that the electronic factors are also 
involved in the inhibition of CYP2A6, as expressed by µ and RPCG descriptors. Hence, these descriptors 
reflect the ability of the compounds to participate in polar interactions, suggesting that higher molecular 
polarity will correspond to lower activity.  
An interesting feature to consider from Equations (2) and (3) is the highly significant contribution of the 
electronic parameter Ehomo. The cavity in the substrate-binding site of CYP2A6 is strongly hydrophobic and 
this characteristic is due to the presence of several amino acid residues of phenylalanine. Thus, Ehomo 
parameter suggests a π-π and / or n-π interaction between OSCs and phenylalanine residues. 
According to previous studies concerning the catalytic versatility of cytochrome P450 [2], regarding the 
functional active oxygen of heme groups, it has been postulated that this group shows nucleophilic and/or 
electrophilic properties catalyzing different type of reactions such as aldehyde deformilations, epoxidations 
and/or hydroxylation. 
On another note, the analysis of equation (4), which only considers monosulfides, suggests that the 
electrons donor ability of these compounds, expressed through Ehomo parameter, plays a critical role in the 
interaction with CYP2A6. Thus, at higher Ehomo energy of monosulfides, a greater inhibitory capacity can be 
observed. In short, from the analysis of the equation, it is possible to infer that the monosulfides could act 
as nucleophiles and interact with hydroperoxo-iron forms and/or oxenoid-iron from Heme group. However, 
the interaction efficiency between monosulfides-CYP2A6 also depends on the hydrophobicity, or 
alternatively on the lower polarity that these compounds present, as reflected by Equations (1) and (2).  
An important aspect to mention is that the ELumo parameter was not significant as a descriptor variable 
in any of the models investigated. This fact suggests that in the case of the disulfides, the ability to accept 
electrons was not relevant to the CYP2A6-disulfide interaction. Thus, it is possible to postulate that the 
inhibitory potency of the disulfides depends mainly on geometric and electronic factors. 
 To further investigate the OSCs-CYP2A6 binding, a PLS-1 analysis was carried out. Analyzing the model 
coefficients (Figure 6), it was observed that the geometric terms E1u, E3u, and SPAM play an essential role 
in the model fit, in agreement with the MLR technique results. This aspect indicates the crucial role of steric 
factors (including non-specific Van der Waals interactions) in the inhibitory activity exerted by such 
compounds. The other molecular parameters showed the importance of the electronic aspects of the OSC-
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CYP2A6 interaction. The presence of RNCG, µ and LDip coefficients in the model indicates that an increase 
in the molecular polarity plays a negative effect on the inhibitory activity of the OSCs; which fully 
corresponds with the current knowledge on the hydrophobic nature of the active site. Finally, the model 
showed that in the case of monosulfides, Ehomo electronic parameter, or the ability to donate electrons, is a 
significant factor in the enzyme-inhibitor binding. 
Conclusions 
This work allows obtaining a better understanding of the mechanisms involved between the enzyme 
CYP2A6 and OSCs. The obtained results indicate that hydrophobic and steric factors govern the union, 
while electronic factors via the electrons donor ability are strongly involved in the case of monosulfides, 
which could act as nucleophiles and interact with hydroperoxo-iron forms and/or iron-oxenoid from Heme 
groups. It was also possible to conclude that the inhibitory effect of the disulfides depends mainly on 
geometric and electronic factors. Furthermore, it was determined that an increase in the molecular polarity 
exerts a negative effect on the inhibitory activity of the tested compounds, which corresponds with 
previous studies that indicate a high hydrophobicity of the enzyme active site.  
On the other side, this study provides evidence of the enormous potential of WHIM descriptors for the 
development of QSAR models. 
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